Login to Your Account

Clinic Roundup

Friday, December 2, 2011
• Auxilium Pharmaceuticals Inc., of Malvern, Pa., said the first patient was dosed in its Phase IIa trial of Xiaflex (collagenase clostridium histolyticum) in idiopathic adhesive capsulitis of the shoulder, also known as frozen shoulder syndrome. The trial is expected to enroll about 50 adults and will assess the drug's safety and efficacy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription